Home > Income Statement > CORONA REMEDIES

CORONA REMEDIES
Operating Profit

    Back to Income Statement
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Operating Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Operating Profit (Excl OI) ₹240 Cr₹1,547 Cr₹128 Cr₹128 Cr

What is the latest Operating Profit of CORONA REMEDIES ?

The latest Operating Profit ratio of CORONA REMEDIES is ₹240 Cr based on Mar2026 Consolidated results.
Year Operating Profit
Mar2026₹240 Cr
Mar2025₹1,547 Cr
Mar2024₹128 Cr
Mar2023₹128 Cr

How is Operating Profit of CORONA REMEDIES Trending?

Years Operating Profit % Change
Mar2026 ₹240 Cr
-84.49
Mar2025 ₹1,547 Cr
1,109.05
Mar2024 ₹128 Cr
0.00
Mar2023 ₹128 Cr -

Compare Operating Profit of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹13,121.6 Cr 3% 3.7% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹461,848.0 Cr -1.4% -1.3% 21.5% Stock Analytics
DIVIS LABORATORIES ₹225,648.0 Cr 2.7% 16.1% 38.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,109.0 Cr -1.5% -3.3% 35.6% Stock Analytics
CIPLA ₹117,139.0 Cr -0.7% 1.4% -2% Stock Analytics
DR REDDYS LABORATORIES ₹100,328.0 Cr 3.9% -1.8% 0.4% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

3%

3.7%

NA
SENSEX

-0.6%

1.1%

-3.2%


You may also like the below Video Courses